A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Determine the Efficacy, Safety, and Tolerability of AMG 785 in Adults With a Fresh Unilateral Hip Fracture, Status Post Surgical Fixation
Latest Information Update: 30 Jan 2023
At a glance
- Drugs Romosozumab (Primary)
- Indications Hip fracture
- Focus Therapeutic Use
- Acronyms STARTT-Hip
- Sponsors Amgen
- 25 Nov 2020 New trial record